| BSE: 531686 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE537C01019 |
| BSE 00:00 | 15 Nov | 0.51 |
-0.02 (-3.77%) |
OPEN
0.52 |
HIGH
0.52 |
LOW
0.51 |
| NSE 05:30 | 01 Jan | Advik Laboratories Ltd Not listed in NSE |
| OPEN | 0.52 |
| PREVIOUS CLOSE | 0.53 |
| VOLUME | 3051 |
| 52-Week high | 2.99 |
| 52-Week low | 0.51 |
| P/E | |
| Mkt Cap.(Rs cr) | 1 |
| Buy Price | 0.55 |
| Buy Qty | 79.00 |
| Sell Price | 0.51 |
| Sell Qty | 149.00 |
Advik Laboratories Limited is engaged in the manufacture and sale of pharmaceutical products in India. It offers ethical, generic, and over the counter drugs in various formulations. The company's generic product portfolio comprises antibacterial; antiallergics; antifungals; analgesic, antipyretic, and anti-inflammatory; antihypertensives; anthelminthics; antimalarials; corticosteroids; erectile d...> More
| Parameter | Values | ||
| Market Cap | ( cr) |
1 | |
| EPS - TTM | () |
[*S] | - |
| P/E Ratio | (X) | [*S] | - |
| Face Value | () |
10 | |
| Latest Dividend | (%) | - | |
| Latest Dividend Date | - | ||
| Dividend Yield | (%) | 0.00 | |
| Book Value / Share | () |
[*S] | 4.70 |
| P/B Ratio | () |
[*S] | 0.11 |
Submission Of Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2019 As
Announcement under Regulation 30 (LODR)-Newspaper Publication
Board Meeting Intimation for Notice Of Board Meeting To Consider And Approve The Unaudited Financial
CERTIFICATE UNDER REGULATION 40(9) OF THE SEBI (LISTING OBLIGATION AND DISCLOSURE REQUIREMENTS REGUL
Particulars ( cr) |
Sep 2019 | Sep 2018 | % Chg |
| Net Sales | 0.82 | - | |
| Other Income | - | ||
| Total Income | 0.83 | - | |
| Total Expenses | 0.15 | 1 | -85 |
| Operating Profit | -0.15 | -0.17 | 11.76 |
| Net Profit | -0.28 | -0.31 | 9.68 |
| Equity Capital | 19.11 | 19.11 | - |
| Company | Price() |
Chg (%) | Mkt Cap ( CR) |
| Hind.Bio Science | 3.18 | 1.92 | 3.26 |
| Beryl Drugs | 5.21 | 4.62 | 2.64 |
| Bacil Pharma | 1.96 | -4.39 | 1.15 |
| Advik Labs. | 0.51 | -3.77 | 0.97 |
| Chemo Pharma Lab | 5.88 | -4.85 | 0.88 |
| Welcure Drugs | 0.56 | 3.70 | 0.76 |
| Kabra Drugs | 0.76 | 4.11 | 0.33 |
|
|
|
| Period | BSE | NSE | Sensex | NIFTY |
| 1 Week | -10.53% | NA | 0.08% | -0.11% |
| 1 Month | -21.54% | NA | 4.81% | 4.09% |
| 3 Month | -44.57% | NA | 8.16% | 7.85% |
| 6 Month | NA | NA | 8.73% | 6.62% |
| 1 Year | -82.94% | NA | 14.45% | 12.04% |
| 3 Year | -91.39% | NA | 53.42% | 46.70% |
| Today's Low/High | 0.51 |
|
0.52 |
| Week Low/High | 0.51 |
|
1.00 |
| Month Low/High | 0.51 |
|
1.00 |
| YEAR Low/High | 0.51 |
|
3.00 |
| All TIME Low/High | 0.51 |
|
53.00 |
Promoters
Banks/FIs
FIIs
Insurance
Mutual Funds
Indian Public
Custodians
Other
